Human Umbilical Cord Blood Mononuclear Cells (Peking University Third Hospital)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHuman Umbilical Cord Blood Mononuclear Cells (Peking University Third Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapy

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsDiabetic Foot

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesThe Third Affiliated Hospital Of Beijing University

China Registration ClassN/A

Develop Information

Active CompaniesThe Third Affiliated Hospital Of Beijing University

Inactive CompaniesN/A

Active IndicationsDiabetic Foot

Inactive IndicationsN/A

Other Information

ATC CodeN/A